» Articles » PMID: 32041789

Porphyromonas Gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism

Overview
Journal Infect Immun
Date 2020 Feb 12
PMID 32041789
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Programmed death-ligand 1 (PD-L1/B7-H1) serves as a cosignaling molecule in cell-mediated immune responses and contributes to chronicity of inflammation and the escape of tumor cells from immunosurveillance. Here, we investigated the molecular mechanisms leading to PD-L1 upregulation in human oral carcinoma cells and in primary human gingival keratinocytes in response to infection with (), a keystone pathogen for the development of periodontitis. The bacterial cell wall component peptidoglycan uses bacterial outer membrane vesicles to be taken up by cells. Internalized peptidoglycan triggers cytosolic receptors to induce PD-L1 expression in a myeloid differentiation primary response 88 (Myd88)-independent and receptor-interacting serine/threonine-protein kinase 2 (RIP2)-dependent fashion. Interference with the kinase activity of RIP2 or mitogen-activated protein (MAP) kinases interferes with inducible PD-L1 expression.

Citing Articles

Intra-tumoral bacteria in head and neck cancer: holistic integrative insight.

Meng Y, Deng J, Deng W, Sun Z Cancer Biol Med. 2025; 22(2).

PMID: 39969204 PMC: 11899592. DOI: 10.20892/j.issn.2095-3941.2024.0311.


[Research and Progress on the Association of Porphyromonas gingivalis with Lung Cancer].

Yin Y, Zhang J, Guo Q, Shen C Zhongguo Fei Ai Za Zhi. 2024; 27(10):799-804.

PMID: 39631837 PMC: 11629007. DOI: 10.3779/j.issn.1009-3419.2024.101.28.


The emerging role of bacterial extracellular vesicles in human cancers.

Liang A, Korani L, Yeung C, Tey S, Yam J J Extracell Vesicles. 2024; 13(10):e12521.

PMID: 39377479 PMC: 11460218. DOI: 10.1002/jev2.12521.


Roles of intralesional bacteria in the initiation and progression of oral squamous cell carcinoma.

Luo Z, Lv S, Lou F, Yan L, Xu J, Kang N Cancer Med. 2024; 13(18):e70209.

PMID: 39300932 PMC: 11413416. DOI: 10.1002/cam4.70209.


Periodontal pathogens and cancer development.

Zhou Y, Meyle J, Groeger S Periodontol 2000. 2024; 96(1):112-149.

PMID: 38965193 PMC: 11579836. DOI: 10.1111/prd.12590.


References
1.
Zitvogel L, Kroemer G . Targeting PD-1/PD-L1 interactions for cancer immunotherapy. Oncoimmunology. 2012; 1(8):1223-1225. PMC: 3518493. DOI: 10.4161/onci.21335. View

2.
Trieb K, Dorfinger K, Neuhold N, Selzer E, Wilfing A, Czernin S . Suramin affects differentiated and undifferentiated human thyroid epithelial cells in vitro. J Endocrinol. 1992; 134(3):505-11. DOI: 10.1677/joe.0.1340505. View

3.
Kobayashi K, Inohara N, Hernandez L, Galan J, Nunez G, Janeway C . RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002; 416(6877):194-9. DOI: 10.1038/416194a. View

4.
Chen Y, Zhang J, Guo G, Ruan Z, Jiang M, Wu S . Induced B7-H1 expression on human renal tubular epithelial cells by the sublytic terminal complement complex C5b-9. Mol Immunol. 2008; 46(3):375-83. DOI: 10.1016/j.molimm.2008.10.026. View

5.
Ellis T, Kuehn M . Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010; 74(1):81-94. PMC: 2832350. DOI: 10.1128/MMBR.00031-09. View